Abeona Shares Higher After Pricing Stock Offering -- Biotech Movers

The clinical-stage biopharmaceutical firm said Oct. 16 it has priced an underwritten public offering of five million shares at $16 apiece.
Stocks quotes in this article: ABEO, ARDX, INSY

Shares of Abeona Therapeutics Inc. (ABEO) rose 1.8% to $17 in premarket trading on Tuesday, Oct. 17, after the company priced an underwritten public offering of five million shares at $16 apiece, which would generate gross proceeds of $80 million. Abeona has also given underwriters a 30-day option to buy up to an additional 750,000 shares.

Abeona said it plans to use the net proceeds for working capital and corporate purposes.

Meanwhile, shares of Ardelyx Inc. (ARDX) were up 4.6% to $6.70 after closing at $6.40 on Monday, down 12%.

The Fremont, Calif.-based firm on Monday morning said data from preclinical studies have shown that "tenapanor works to reduce abdominal pain caused by irritable bowel syndrome with constipation (IBS-C) through the inhibition of TRPV-1 dependent signaling."

Among the other biotech stock movers was Insys Therapeutics Inc. (INSY) , up 3.8% to $7.70.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.
TAGS: Investing | U.S. Equity | Healthcare | Drug Approvals | Stocks

More from Healthcare

Weighing the Risk-Reward in Turning Point Therapeutics

Bruce Kamich

What does it mean when a stock is called very speculative?

Covetrus Needs to Build a Base After Surge in Share Price

Bruce Kamich

Shares of the provider of animal health technology could afford to see more development and sideways price action after their big post-earnings jump.

Does Planet Fitness Look Fit for Investors?

Bruce Kamich

Let's find a trainer versed in technical analysis as we check out the charts.

InMode Has Tripled Since Its IPO: Here's How to Play It Now

Bruce Kamich

Let's check out the charts of this medical technologies company.

Trade Walgreens for the Same Reason It Might Go Private

Mark Sebastian

I see upside back to above $70 regardless of whether the company gets taken private.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight